| Emily Blair, MD, DO | |
|
1735 Post Road, Ob/gyn Of Fairfield County, Fairfield, CT 06824 | |
| (203) 256-3990 | |
| (203) 255-0688 |
| Full Name | Emily Blair |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 1735 Post Road, Fairfield, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467472654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 000249 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Greenwich Hospital Association - | Greenwich, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
BRCA testing is becoming more common in women diagnosed with breast cancer by the age of 40 years in the USA, research shows, with concerns about genetic risk influencing surgical decisions.
Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.
A 16 year old cancer victim who was inadvertently given more than 17 overdoses of radiation during treatment for a brain tumour, has died at home nine months later.
› Verified 8 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
BRCA testing is becoming more common in women diagnosed with breast cancer by the age of 40 years in the USA, research shows, with concerns about genetic risk influencing surgical decisions.
Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.
A 16 year old cancer victim who was inadvertently given more than 17 overdoses of radiation during treatment for a brain tumour, has died at home nine months later.
› Verified 8 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
BRCA testing is becoming more common in women diagnosed with breast cancer by the age of 40 years in the USA, research shows, with concerns about genetic risk influencing surgical decisions.
Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.
A 16 year old cancer victim who was inadvertently given more than 17 overdoses of radiation during treatment for a brain tumour, has died at home nine months later.
› Verified 8 days ago
| Entity Name | Obstetrics And Gynecology Of Fairfield County Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255524542 PECOS PAC ID: 9830088582 Enrollment ID: O20040311001213 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
BRCA testing is becoming more common in women diagnosed with breast cancer by the age of 40 years in the USA, research shows, with concerns about genetic risk influencing surgical decisions.
Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.
A 16 year old cancer victim who was inadvertently given more than 17 overdoses of radiation during treatment for a brain tumour, has died at home nine months later.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Blair, MD, DO 1735 Post Road, Ob/gyn Of Fairfield County, Fairfield, CT 06824 Ph: (203) 256-3990 | Emily Blair, MD, DO 1735 Post Road, Ob/gyn Of Fairfield County, Fairfield, CT 06824 Ph: (203) 256-3990 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
BRCA testing is becoming more common in women diagnosed with breast cancer by the age of 40 years in the USA, research shows, with concerns about genetic risk influencing surgical decisions.
Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.
A 16 year old cancer victim who was inadvertently given more than 17 overdoses of radiation during treatment for a brain tumour, has died at home nine months later.
› Verified 8 days ago
Dr. Patricia Ines Abruna, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1735 Post Rd, Fairfield, CT 06824 Phone: 203-256-3379 Fax: 203-256-3993 | |
Mr. Jose Reyes, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 309 Stillson Rd, Fairfield, CT 06825 Phone: 203-366-8700 Fax: 203-367-8080 | |
Peter Vandell, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1735 Post Road, Ob/gyn Of Fairfield County, Fairfield, CT 06824 Phone: 203-256-3990 Fax: 203-255-0688 | |
Dr. Elenita Espina, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 309 Stillson Rd, Fairfield, CT 06825 Phone: 203-366-8700 Fax: 203-367-8080 | |
Dr. Michael B Doyle, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 405 N Cedar Rd, Fairfield, CT 06824 Phone: 203-209-4911 | |
Dr. Aubrey Rauktys, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2150 Black Rock Tpke Ste 201, Fairfield, CT 06825 Phone: 203-693-4593 | |
Steven Cassell, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1735 Post Road, Ob/gyn Of Fairfield County, Fairfield, CT 06824 Phone: 203-256-3990 Fax: 203-255-0688 |